The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status

Jenny C Ngai, Fanny W Ko, Susanna S Ng, Kin-Wang To, Mabel Tong, David S Hui, Jenny C Ngai, Fanny W Ko, Susanna S Ng, Kin-Wang To, Mabel Tong, David S Hui

Abstract

Background and objective: Severe acute respiratory syndrome (SARS) emerged in 2003 and its long-term sequelae remain largely unclear. This study examined the long-term outcome of pulmonary function, exercise capacity, health and work status among SARS survivors.

Methods: A prospective cohort study of SARS patients at the Prince of Wales Hospital, Hong Kong was conducted, with serial assessments of lung function, 6MWD and 36 item Short Form General Health Survey at 3, 6, 12, 18 and 24 months after disease onset. The work status was also recorded.

Results: Serial assessments were completed by 55 of the 123 (39.9%) subjects, of whom 27 were health-care workers (HCW). The mean age of the group was 44.4 (SD 13.2) years and 19 (34.5%) were males. At 24 months, 10 (18.2%), 9 (16.4%), 6 (10.9%) and 29 (52.7%) subjects had FEV(1), FVC, TLC and DL(CO) < 80% of predicted values, respectively. The mean (SD) 6MWD increased significantly from 439.0 (89.1) m at 3 months to 460.1 (102.8) m at 6 months (P 0.016) and became steady after 6 months. However, 6MWD and 36 item Short Form General Health Survey scores were lower than the normal population throughout the study. Moreover, 29.6% of HCW and 7.1% of non-HCW had not returned to work 2 years after illness onset.

Conclusions: This 2-year study of a selected population of SARS survivors, showed significant impairment of DL(CO), exercise capacity and health status persisted, with a more marked adverse impact among HCW.

Figures

Figure 1
Figure 1
Health status (Short Form General Health Survey—SF‐36) among survivors of severe acute respiratory syndrome at 3, 6, 12, 18 and 24 months after illness onset in comparisons with Hong Kong normative data stratified into different age groups. The vertical axis represents the SF‐36 domain score in mean (SD) ranging from 0 (minimum) to 100 (maximum), whereas the horizontal axis defines age groups in years. BP, bodily pain; GH, general health; MH, mental health; PF, physical functioning; RE, emotional problem; RP, physical problems; SF, social functioning; VT, vitality. *Significant at P < 0.01; **Significant at P < 0.03; #Significant at P < 0.01.

References

    1. Drosten C, Gunther S, Preiser W et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 2003; 348: 1967–76.
    1. Fouchier RA, Kuiken T, Schutten M et al. Aetiology: ss's postulates fulfilled for SARS virus. Nature 2003; 423: 240.
    1. World Health Organization . Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July, 2003. [Accessed 21 April 2004.] Available from URL:
    1. Herridge MS, Cheung AM, Tansey CM et al. One‐year outcomes in survivors of the acute respiratory distress syndrome. N. Engl. J. Med. 2003; 348: 683–93.
    1. Simpson DL, Goodman M, Spector SL et al. Long‐term follow‐up and bronchial reactivity testing in survivors of the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 1978; 117: 449–54.
    1. Lakshminarayan S, Hudson LD. Pulmonary function following the adult respiratory distress syndrome. Chest 1978; 74: 489–90.
    1. Peters JI, Bell RC, Prihoda TJ et al. Clinical determinants of abnormalities in pulmonary functions in survivors of the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 1989; 139: 1163–8.
    1. Orme J Jr, Romney JS, Hopkins RO et al. Pulmonary function and health‐related quality of life in survivors of acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 2003; 167: 690–4.
    1. Ong KC, Ng AWK, Lee LSU et al. Pulmonary function and exercise capacity in survivors of severe acute respiratory syndrome. Eur. Respir. J. 2004; 24: 436–42.
    1. Xie L, Liu Y, Xiao Y et al. Follow‐up study on pulmonary function and lung radiographic changes in rehabilitating severe acute respiratory syndrome patients after discharge. Chest 2005; 127: 2119–24.
    1. Ng CK, Chan JW, Kwan TL et al. Six month radiological and physiological outcomes in severe acute respiratory syndrome (SARS) survivors. Thorax 2004; 59: 889–91.
    1. Hui DS, Joynt GM, Wong KT et al. The impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors. Thorax 2005; 60: 401–9.
    1. Hui DS, Wong KT, Ko FW et al. The 1‐year impact of severe acute respiratory syndrome on pulmonary function, exercise capacity, and quality of life in a cohort of survivors. Chest 2005; 128: 2247–61.
    1. Xie L, Liu Y, Fan B et al. Dynamic changes of serum SARS‐coronavirus IgG, pulmonary function and radiography in patients recovering from SARS after hospital discharge. Respir. Res. 2005; 6: 5.
    1. Tansey CM, Louie M, Loeb M et al. One year outcomes and health care utilization in survivors of severe acute respiratory syndrome. Arch. Intern. Med. 2007; 167: 1312–20.
    1. Ong KC, Ng AW, Lee L et al. 1‐year pulmonary function and health status in survivors of severe acute respiratory syndrome. Chest 2005; 128: 1393–400.
    1. Beijing Respiratory Experts Panel of the Medical Staff Severe Acute Respiratory Syndrome Patients . A follow‐up study of the lung function and the chest CT changes in medical staff with severe acute respiratory syndrome in Beijing. Zhonghua Jie He He Hu Xi Za Zhi 2005; 28: 10–12.
    1. Su MC, Hsieh YT, Wang YH et al. Exercise capacity and pulmonary function in hospital workers recovered from severe acute respiratory syndrome. Respiration 2007; 74: 511–16.
    1. Liu YX, Ye YP, Zhang P et al. Changes in pulmonary function in SARS patients during the three‐year convalescent period. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2007; 19: 536–8.
    1. Lee N, Hui DS, Wu A et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med. 2003; 348: 1986–94.
    1. Centers for Disease Control and Prevention . Severe acute respiratory syndrome (SARS) updated interim U.S. case definition, 2003. [Accessed 20 Apr 2003.] Available from URL:
    1. Sung JJ, Wu A, Joynt GM et al. Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak. Thorax 2004; 59: 414–20.
    1. Lam CL, Gandek B, Ren XS et al. Tests of scaling assumptions and construct validity of the Chinese (HK) version of the SF 36 health survey. J. Clin. Epidemiol. 1998; 51: 1139–47.
    1. Lam CL, Lauder IJ, Lam TP et al. Population based norming of the Chinese (HK) version of the SF 36 health survey. Hong Kong Pract. 1999; 21: 460–70.
    1. American Thoracic Society . Standardization of spirometry, 1994 update. Am. J. Respir. Crit. Care Med. 1995; 152: 1107–36.
    1. Da Costa JL. Pulmonary function studies in healthy Chinese adults in Singapore. Am. Rev. Respir. Dis. 1971; 104: 128–31.
    1. Burrows B, Kasik JE, Niden AH et al. Clinical usefulness of the single‐breath pulmonary diffusing capacity test. Am. Rev. Respir. Dis. 1961; 84: 789–806.
    1. Ip M, Ko F, Lau A et al. Updated spirometric reference values for adult Chinese in Hong Kong and implications on clinical utilization. Chest 2006; 129: 384–92.
    1. Ip M, Lam WK, Lai A et al. Reference values of diffusing capacity of non‐smoking Chinese in Hong Kong. Respirology 2007; 12: 599–606.
    1. ATS/ERS Statement on respiratory muscle testing. Am. J. Respir. Crit. Care Med. 2002; 166: 518–624.
    1. Koulouris N, Mulvey DA, Laroche CM et al. Comparison of two different mouthpieces for the measurement of Pimax and Pemax in normal and weak subjects. Eur. Respir. J. 1988; 9: 863–7.
    1. Neff TA, Stocker R, Frey HR et al. Long‐term assessment of lung function in survivors of severe ARDS. Chest 2003; 123: 845–53.
    1. Cheung AM, Tansey CM, Tomlinson G et al. Two year outcomes, health care use, and costs of survivors of Acute Respiratory Distress Syndrome. Am. J. Respir. Crit. Care Med. 2006; 174: 538–44.
    1. Schelling G, Stoll C, Vogelmeier C et al. Pulmonary function and health‐related quality of life in a sample of long‐term survivors of the acute respiratory distress syndrome. Intensive Care Med. 2000; 26: 1304–11.
    1. Hughes JM, Pride NB. In defense of the carbon monoxide transfer coefficient KCO (TL/VA). Eur. Respir. J. 2001; 17: 168–74.
    1. MacIntyre N, Crapo RO, Viegi G et al. Standardisation of the single‐breath determination of carbon monoxide uptake in the lung. Eur. Respir. J. 2005; 26: 720–35.
    1. Chang YC, Yu CJ, Chang SC et al. Pulmonary sequelae in convalescent patients after severe acute respiratory syndrome: evaluation with thin‐section CT. Radiology 2005; 236: 1067–75.
    1. Wong KT, Antonio GE, Hui DS et al. Severe acute respiratory syndrome thin‐section computed tomography features, temporal changes and clinical radiological correlation during the convalescent period. J. Comput. Assist. Tomogr. 2004; 28: 790–5.
    1. Ketai L, Paul NS, Wong KT. Radiology of severe acute respiratory syndrome (SARS): the emerging pathologic‐radiologic correlates of an emerging disease. J. Thoracic Imaging 2006; 21: 276–83.
    1. Hsiao CH, Wu MZ, Chen CL et al. Evolution of pulmonary pathology in severe acute respiratory syndrome. J. Formos. Med. Assoc. 2005; 104: 75–81.
    1. Tse GM, To KF, Chan PK et al. Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS). J. Clin. Pathol. 2004; 57: 260–5.
    1. Hwang DM, Chamberlain DW, Poutanen SM et al. Pulmonary pathology of severe acute respiratory syndrome in Toronto. Mod. Pathol. 2005; 18: 1–10.
    1. Tsai LK, Hsieh ST, Chao CC et al. Neuromuscular disorders in severe acute respiratory syndrome. Arch. Neurol. 2004; 61: 1669–73.
    1. Wu KK, Chan SK, Ma TM. Posttraumatic stress, anxiety, and depression in survivors of severe acute respiratory syndrome (SARS). J. Trauma. Stress 2005; 18: 39–42.
    1. Lee AM, Wong JG, McAlonan GM et al. Stress and psychological distress among SARS survivors 1 year after the outbreak. Can. J. Psychiatry 2007; 52: 233–40.
    1. Siu JY. The SARS‐associated stigma of SARS victims in the post‐SARS era of Hong Kong. Qual. Health Res. 2008; 18: 729–38.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner